Recursion Pharmaceuticals, Inc. ( NASDAQ: RXRX) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 4:05 PM EDT ...

Hamilton, Bermuda, September 11th, 2025, ChainwireOnRe, an onchain asset manager delivering institutional-grade yield to ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...

OnRe launched OnRe Points, a rewards program designed to incentivize meaningful participation in the ONyc ecosystem.

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Biodexa Pharmaceuticals PLC (BDRX) has initiated its first clinical site in the U.S. for a phase 3 trial of eRapa, an oral ...

Autonomous AI agents are more than just extensions of vendor tools. They’re credentialed actors who connect and execute, and ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

OnRe points mark a shift from passive token farming to active ecosystem building. By rewarding ONyc’s deployment across DeFi ...

Pharma layoffs in 2025 have surged, with thousands facing job cuts as companies like BMS and Novartis streamline operations.